no statement of use filed
on 28 Jan 2019
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
86852662 filed on 17th Dec 2015
Registration Number
N/A
Correspondent Address
Bruce W. Longbottom
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorde Read More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
No 86852662
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
28th Jan 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
28th Jan 2019 | ABANDONMENT - NO USE STATEMENT FILED |
16th Jun 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
15th Jun 2018 | EXTENSION 4 GRANTED |
13th Jun 2018 | EXTENSION 4 FILED |
13th Jun 2018 | TEAS EXTENSION RECEIVED |
23rd Nov 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
21st Nov 2017 | EXTENSION 3 GRANTED |
21st Nov 2017 | EXTENSION 3 FILED |
21st Nov 2017 | TEAS EXTENSION RECEIVED |